Novo Holdings announced the acquisition of Catalent, Inc. (NYSE: CTLT).
Novo Holdings $16.5 B. Acquisition of Catalent Secures Production Demand for Weight-loss Drug Wegovy
Two RTP-Rooted Companies Form Foundational Gene Editing Partnership
Two RTP-Rooted Companies Form Foundational Gene Editing Partnership By Alex KeownMay 26, 2023 Two companies with deep roots in Research Triangle Park have established a multi-target partnership for the development [….]
Research Triangle Park Q1 2023 News Recap – Expansions and Acquisitions Abound
Research Triangle Park Q1 2023 News Recap – Expansions and Acquisitions Abound By Alex KeownApril 3, 2023 Eli Lilly expands RTP site Pharma giant Eli Lilly announced plans to invest [….]
Novo Nordisk Donates $6 Million to Durham Tech Workforce Training Center
Pharma giant Novo Nordisk increased its support for Durham Technical Community Collegeand its Biotechnology Manufacturing program through a $6 million donation to support the construction and outfitting of a new 35,000-square-foot Life Sciences Training Center that will train a new generation of talent.